Email

G *HS Cc: BO who.int<mailto {MO who.int>; Gary (Public Health Agency of Canada) Kobinger; nih.gov<mailto: nih.gov> [C] Olinger; Peter (NIH/NIAID) [E] Jahrling; Mike Hensley; who.int<mailto: who.int>; Larry Zeitlin; Lisa (NIH/NIAID) [E] Hensley; Miles Brennan; Marshall Hoke; Ho who. int<mailto {j@who.int>; deborah scott; Shindo, Nikki; HR @ cm ail.com<mailto HO email.com> ; Tara Nyhuis Subject: RE: Combining the existing Phase 1 with a Therapeutic Portion Hello Frederick, Please find attached an edited version of the document (only very minor edits). The document is very well done and provides a nice overview of what is available. The document I received however did not contain sections 5 and higher as listed in the Content section (not sure if this was intentional or not). Thanks, Trina